Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
229
-
Total 13F shares, excl. options
-
19.7M
-
Shares change
-
-285K
-
Total reported value, excl. options
-
$1.29B
-
Value change
-
-$20.1M
-
Put/Call ratio
-
0.64
-
Number of buys
-
116
-
Number of sells
-
-98
-
Price
-
$65.25
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q2 2025
257 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q2 2025.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 229 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.7M shares
of 22.3M outstanding shares and own 88.54% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.58M shares), VANGUARD GROUP INC (1.28M shares), MILLENNIUM MANAGEMENT LLC (1M shares), Global Alpha Capital Management Ltd. (862K shares), STATE STREET CORP (716K shares), Deep Track Capital, LP (700K shares), CITADEL ADVISORS LLC (570K shares), DIMENSIONAL FUND ADVISORS LP (554K shares), Ranger Investment Management, L.P. (534K shares), and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (491K shares).
This table shows the top 229 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.